EFFECTS OF CHEMOTHERAPEUTIC AND IMMUNOSUPPRESSIVE DRUGS ON THE PRODUCTION OF ERYTHROPOIETIN IN HUMAN HEPATOMA CULTURES

被引:36
作者
WOLFF, M [1 ]
JELKMANN, W [1 ]
机构
[1] UNIV BONN, DEPT PHYSIOL, NUSSALLEE 11, W-5300 BONN 1, GERMANY
关键词
ERYTHROPOIETIN; CHEMOTHERAPY; MALIGNANT DISEASES; ANEMIA;
D O I
10.1007/BF01737686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of agents used in combination chemotherapy were studied on erythropoietin synthesis in cultures of the human hepatoma cell line, HepG2. Erythropoietin was measured by radioimmunoassay in the culture media after 24-h treatment periods. The RNA synthesis-inhibiting drugs daunorubicin, cyclophosphamide, ifosfamide, and cis-diamine-dichloroplatinum produced a dose-dependent decrease of the production of erythropoietin. Inhibition was also induced by the tubulin-binding agents vincristine and colchicine and the immunosuppressive agents azathioprine and cyclosporin A. The DNA synthesis-inhibiting drugs methotrexate and cytosine arabinoside, the antimycotics 5-fluorocytosine and amphotericin B, and glucocorticoids did not inhibit. Viability studies showed that the inhibition of erythropoietin production was partly correlated with cytotoxicity. These data could be relevant with respect to recombinant erythropoietin replacement therapy in tumor-associated anemia.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 30 条
[21]   EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANTICANCER DRUG-INDUCED ANEMIA [J].
MATSUMOTO, T ;
ENDOH, K ;
KAMISANGO, K ;
AKAMATSU, K ;
KOIZUMI, K ;
HIGUCHI, M ;
IMAI, N ;
MITSUI, H ;
KAWAGUCHI, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (04) :463-468
[22]   ERYTHROPOIETIN RESPONSE TO ANEMIA IN CHILDREN WITH SICKLE-CELL DISEASE AND FANCONIS HYPOPROLIFERATIVE ANEMIA [J].
MCGONIGLE, RJS ;
OHENEFREMPONG, K ;
LEWY, JE ;
FISHER, JW .
ACTA HAEMATOLOGICA, 1985, 74 (01) :6-9
[23]   PHASE-I-II TRIAL OF ERYTHROPOIETIN IN THE TREATMENT OF CISPLATIN-ASSOCIATED ANEMIA [J].
MILLER, CB ;
PLATANIAS, LC ;
MILLS, SR ;
ZAHURAK, ML ;
RATAIN, MJ ;
ETTINGER, DS ;
JONES, RJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (02) :98-103
[24]   DECREASED ERYTHROPOIETIN RESPONSE IN PATIENTS WITH THE ANEMIA OF CANCER [J].
MILLER, CB ;
JONES, RJ ;
PIANTADOSI, S ;
ABELOFF, MD ;
SPIVAK, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (24) :1689-1692
[26]   ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA OF MALIGNANCY ASSOCIATED WITH NEOPLASTIC BONE-MARROW INFILTRATION [J].
OSTER, W ;
HERRMANN, F ;
GAMM, H ;
ZEILE, G ;
LINDEMANN, A ;
MULLER, G ;
BRUNE, T ;
KRAEMER, HP ;
MERTELSMANN, R .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :956-962
[27]   INAPPROPRIATE INCREASE IN ERYTHROPOIETIN TITERS DURING CHEMOTHERAPY [J].
PIROSO, E ;
ERSLEV, AJ ;
CARO, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (04) :248-254
[28]  
SCHAPIRA L, 1990, BLOOD, V76, P2354
[29]   ORGAN DISTRIBUTION OF ERYTHROPOIETIN MESSENGER-RNA IN NORMAL AND UREMIC RATS [J].
TAN, CC ;
ECKARDT, KU ;
RATCLIFFE, PJ .
KIDNEY INTERNATIONAL, 1991, 40 (01) :69-76
[30]   ENHANCED ERYTHROPOIETIN SECRETION IN HEPATOBLASTOMA CELLS IN RESPONSE TO HYPOXIA [J].
UENO, M ;
SEFERYNSKA, I ;
BECKMAN, B ;
BROOKINS, J ;
NAKASHIMA, J ;
FISHER, JW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04) :C743-C749